CYRX News and Press, CryoPort Inc. From 03/13/23

Cryoport Confirms No Financial Exposure to Silicon Valley Bank PR Newswire NASHVILLE, Tenn. , March 13, 2023 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply...

(NewsDirect) By David Willey, Benzinga Cryoport Inc. (NASDAQ: CYRX) provides the life sciences industry with comprehensive supply chain solutions to support vital therapeutics. By offering a platform of end-to-end, fast and technologically advanced packaging and logistics services, Cr...

--News Direct-- By David Willey, Benzinga Cryoport Inc. (NASDAQ: CYRX) provides the life sciences industry with comprehensive supply chain solutions to support vital therapeutics. By offering a platform of end-to-end, fast and technologically advanced packaging and logistics services,...

Shares of Cryoport ( NASDAQ: CYRX ) on Friday gained 8.8% to $22.41 after the company provided FY 2023 revenue guidance above estimates. CYRX stock was already on a two-day win streak. The company after hours on Thursday reported Q4 GAAP EPS of -$0.24 which missed expect...

Cryoport, Inc. (CYRX) Q4 2022 Earnings Conference Call February 23, 2023 05:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Offi...

CryoPort press release ( NASDAQ: CYRX ): Q4 GAAP EPS of -$0.24 misses by $0.05 . Revenue of $60.36M (+7.0% Y/Y) beats by $2.1M . Adjusted EBITDA was $0.7 million for the fourth quarter of 2022, compared to $2.1 million for the fourth quarter of 2021. Adjusted EBITDA fo...

Cryoport Reports Fourth Quarter and Full Year 2022 Results PR Newswire 2022 revenue reached a record $237 million , commercial revenue up 27% year-over-year Now supporting a record 654 global clinical trials and 10 commercial therapies Entering 2023 w...

Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 PR Newswire NASHVILLE, Tenn. , Feb. 15, 2023 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative t...

Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...

Summary Cryoport has been punished over the last 12 months amid a number of downside catalysts. Shares have recently curled up off 52-week lows, asking the question on whether this is an appropriate time for entry. The company's upcoming FY22 numbers will be telling where the stock ...